there are examples out there with a much higher market cap than us in only phase 2. IHL have 2 phase 2a and 3 phase 1 products and were around 1 billion market cap 6months ago, now around 500 million. You can never directly compare I know but the potential is there for us to see a substantial rerate with more than one product joining phase 3. Rosacea results are huge imo, could trigger the jump we are all hoping and waiting for. Dyor etc
there are examples out there with a much higher market cap than...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.005(1.18%) |
Mkt cap ! $761.8M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 44.5¢ | 42.0¢ | $1.621M | 3.760M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 537736 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 88909 | 19 |
View Market Depth
| Last trade - 14.34pm 13/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |